IVPost
$10 Million Grant to Help Fund New Hope Lodge Facility Matched by Houston Supporters
- Details
- Written by Jennifer Walker
- Category: Health News
Houston-based foundations and organizations, along with donors from across the nation, have matched a $10 million challenge grant offered by the Richard M. Schulze Family Foundation to help build an American Cancer Society Hope Lodge facility and to fund its operating endowment.
National Colorectal Cancer Roundtable Recognizes Leaders in Colorectal Cancer Screening Efforts with 80% by 2018 National Achievement Award
- Details
- Written by American Cancer Society
- Category: Health News
The National Colorectal Cancer Roundtable (NCCRT), an organization co-founded by the American Cancer Society and the Centers for Disease Control and Prevention, recognized seven honorees with the 80% by 2018 National Achievement Award, a national honor recognizing leadership in the ongoing effort to increase colorectal cancer screening rates across the Unites States.
American Cancer Society and Global Center for Medical Innovation Partner to Accelerate Pace of Bringing Research to Clinic
- Details
- Written by IVPost
- Category: Medical News
The American Cancer Society (ACS) is partnering with the Atlanta-based Global Center for Medical Innovation (GCMI) to more rapidly bring groundbreaking research from the lab to the clinic.
Benign paroxysmal positional vertigo (BPPV)
- Details
- Written by Mayo Clinic Insights
- Category: Medical News
Benign paroxysmal positional vertigo (BPPV) is one of the most common causes of vertigo - the sudden sensation that you're spinning or that the inside of your head is spinning.
FTC Approves Fresenius Medical Care AG’s Application for Approval of Proposed Plan to Establish New Outpatient Hemodialysis Clinic
- Details
- Written by IVPost
- Category: Latest News
The Federal Trade Commission has approved an application by Fresenius Medical Care AG & Co. KGaA to establish a new outpatient hemodialysis clinic in Wyoming, Michigan at a location previously divested by Fresenius.
FDA approves first drug for Eosinophilic Granulomatosis with Polyangiitis, a rare disease formerly known as the Churg-Strauss Syndrome
- Details
- Written by Lauren Smith Dyer
- Category: Latest News
The U.S. Food and Drug Administration today expanded the approved use of Nucala (mepolizumab) to treat adult patients with eosinophilic granulomatosis with polyangiitis (EGPA), a rare autoimmune disease that causes vasculitis, an inflammation in the wall of blood vessels of the body. This new indication provides the first FDA-approved therapy specifically to treat EGPA.
Page 31 of 50